Patents by Inventor Mike H. O'Neill

Mike H. O'Neill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Valomaciclovir polymorphs
    Patent number: 9492456
    Abstract: The present invention relates to crystalline forms of valomaciclovir, processes for preparing crystalline forms of valomaciclovir, pharmaceutical compositions thereof and methods of using thereof.
    Type: Grant
    Filed: June 19, 2014
    Date of Patent: November 15, 2016
    Assignee: EPIPHANY BIOSCIENCES, INC.
    Inventors: Mike H. O'Neill, Gregory P. Butke
  • VALOMACICLOVIR POLYMORPHS
    Publication number: 20150051229
    Abstract: The present invention relates to crystalline forms of valomaciclovir, processes for preparing crystalline forms of valomaciclovir, pharmaceutical compositions thereof and methods of using thereof.
    Type: Application
    Filed: June 19, 2014
    Publication date: February 19, 2015
    Inventors: Mike H. O'NEILL, Gregory P. BUTKE
  • Solid forms of an anti-HIV phosphoindole compound
    Patent number: 8470870
    Abstract: Solid forms comprising a compound useful in the treatment, prevention and management of various conditions and diseases are provided herein. In particular, provided herein are solid forms comprising (2-carbamoyl-5-chloro-1H-indol-3-yl)-[3-((E)-2-cyano-vinyl)-5-methyl-phenyl]-(R)-phosphinic acid methyl ester, including salts thereof, having utility for the treatment, prevention and management of conditions and disorders including, but not limited to, human immunodeficiency virus infection.
    Type: Grant
    Filed: March 27, 2009
    Date of Patent: June 25, 2013
    Assignee: Idenix Pharmaceuticals, Inc.
    Inventors: Adel M. Moussa, Mike H. O'Neill, Xiaohong Sheng
  • (Pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal for treatment of cancer and other diseases
    Patent number: 8058437
    Abstract: A novel co-crystal of N?-(7-fluoropyrrolo[1,2a]quinoxalin-4-yl)pyrazine-2-carbohydrazide with oxalic acid is disclosed. The disclosed oxalic acid co-crystal demonstrates cancer cell growth inhibition and is more bioavailable than the corresponding free base when administered as a suspension.
    Type: Grant
    Filed: April 8, 2009
    Date of Patent: November 15, 2011
    Assignee: Novelix Pharmaceuticals, Inc.
    Inventors: Victor J Bauer, Mike H O'Neill, Barbara J Kidon, Burkhard Jansen
  • SOLID FORMS OF AN ANTI-HIV PHOSPHOINDOLE COMPOUND
    Publication number: 20110039803
    Abstract: Solid forms comprising a compound useful in the treatment, prevention and management of various conditions and diseases are provided herein. In particular, provided herein are solid forms comprising (2-carbamoyl-5-chloro-1H-indol-3-yl)-[3-((E)-2-cyano-vinyl)-5-methyl-phenyl]-(R)-phosphinic acid methyl ester, including salts thereof, having utility for the treatment, prevention and management of conditions and disorders including, but not limited to, human immunodeficiency virus infection.
    Type: Application
    Filed: March 27, 2009
    Publication date: February 17, 2011
    Inventors: Adel M. Moussa, Mike H. O'Neill, Xiaohong Sheng
  • NOVEL (PYRROLOQUINOXALINYL) PYRAZINECARBOHYDRAZIDE-OXALIC ACID CO-CRYSTAL FOR TREATMENT OF CANCER AND OTHER DISEASES
    Publication number: 20110034473
    Abstract: A novel co-crystal of N?-(7-fluoropyrrolo[1,2a]quinoxalin-4-yl)pyrazine-2-carbohydrazide with oxalic acid is disclosed. The disclosed oxalic acid co-crystal demonstrates cancer cell growth inhibition and is more bioavailable than the corresponding free base when administered as a suspension.
    Type: Application
    Filed: April 8, 2009
    Publication date: February 10, 2011
    Applicant: NOVELIX PHARMACEUTICALS, INC.
    Inventors: Victor J. Bauer, Mike H. O'Neill, Barbara J. Kidon, Burkhard Jansen
  • VALOMACICLOVIR POLYMORPHS
    Publication number: 20100240681
    Abstract: The present invention relates to crystalline forms of valomaciclovir, processes for preparing crystalline forms of valomaciclovir, pharmaceutical compositions thereof and methods of using thereof.
    Type: Application
    Filed: September 18, 2008
    Publication date: September 23, 2010
    Applicant: EPIPHANY BIOSCIENCES, INC.
    Inventors: Mike H. O'Neill, Gregory P. Butke
  • Polymorphs of 3--(3?,3?-dimethylsuccinyl)betulinic acid di--methyl-D-glucamine
    Patent number: 7799768
    Abstract: The present invention relates to crystalline polymorphs of 3-O-(3?,3?-dimethylsuccinyl)betulinic acid di-N-methyl-D-glucamine salt (“DSB•2NMG)”), pharmaceutical compositions of the same and use of the same as an active pharmaceutical agent in the treatment of HIV related disorders.
    Type: Grant
    Filed: April 12, 2006
    Date of Patent: September 21, 2010
    Assignee: Myrexis, Inc.
    Inventors: Mike H. O'Neill, Gary G. Sweetapple, Randall M. Walker, Arndt Hausherr, Gunter Koch, David E. Martin